This class of drugs was associated with a 20% lower risk of dementia compared to another diabetes medication known as dipeptidyl peptidase-4 (DPP4) inhibitors. SGLT2 inhibitors help lower blood ...
An estimated 50m people live with dementia globally, more than two-thirds of them in low- and middle-income countries. In 2024, the first drugs that can change the course of Alzheimer’s disease ...
Axovant has axed development of its key dementia drug intepirdine after results suggested it actually worsened symptoms compared with placebo. The news sent the neurology-focused Swiss biotech’s ...
Nov. 19, 2024 — Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new ... Earlier Diabetes Diagnosis Linked to Dementia Risk Nov. 19, 2024 ...
It’s also bad news for payers (and Governments), since among the diseases that don’t have effective (and cost-effective) treatments is dementia ... list, set out in May 2017, is transparency ...
There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.